Invention Grant
- Patent Title: BRM targeting compounds and associated methods of use
-
Application No.: US17343341Application Date: 2021-06-09
-
Publication No.: US11702423B2Publication Date: 2023-07-18
- Inventor: Hong Lin , Philip Pitis , Liang Lu , Andrew Paul Combs
- Applicant: Prelude Therapeutics, Incorporated
- Applicant Address: US DE Wilmington
- Assignee: Prelude Therapeutics Incorporated
- Current Assignee: Prelude Therapeutics Incorporated
- Current Assignee Address: US DE Wilmington
- Agency: BakerHostetler
- Main IPC: C07D401/12
- IPC: C07D401/12 ; A61K31/50 ; A61P35/00 ; C07D487/14 ; C07D519/00
Abstract:
The present disclosure provides bifunctional compounds comprising a target protein binding moiety and a E3 ubiquitin ligase binding moiety, and associated methods of use.
Public/Granted literature
- US20220033409A1 BRM TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE Public/Granted day:2022-02-03
Information query
